Applications of 5Alpha-Androst-1-En-3,17-Diol in Industrial Manufacturing

5Alpha-Androst-1-En-3,17-Diol is a specialty raw material used in high-value chemical manufacture. As the original producer, we support demanding industry applications where strict process control and regulatory alignment are essential. Key downstream segments are summarized below.

1. Pharmaceutical Steroid Intermediate Synthesis

Major pharmaceutical companies use this compound as an intermediate in the production of anabolic steroid APIs, particularly for clinical and prescription anabolic treatments. Integration into multistep synthetic pathways requires stringent identity confirmation and trace impurity analysis. Regulatory review focuses on process controls, with full batch traceability and pharmaceutical-grade GMP production.

Industry compliance standards

• EU GMP (Good Manufacturing Practice)
• 21 CFR Part 210/211 (US FDA)
• ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
• Ph. Eur., USP, and JP monographs for related intermediates

Typical usage ratio

• Mapped to target API mass balance, 5%-20% by weight per batch input depending on synthetic route

Downstream process integration

• Charged into the main reaction vessel post-activation of catalyst phase in multi-step organic synthesis (step 2 or 3 of total 5–8 step synthesis)

Final product types

• Finished anabolic steroid APIs for oral or injectable medicinal formulations
• Steroidal precursors for investigational new drug development

2. Veterinary Bulk Drug Manufacture

Animal pharmaceutical producers utilize this raw material as a critical intermediate in the synthesis of veterinary corticosteroids and androgen derivatives. End users apply these agents for livestock growth management and disease treatment, requiring compliance with animal-specific pharmacopoeias and residue limits. Stringent quality control ensures low residual solvent levels and proper documentation for international market release.

Industry compliance standards

• VICH GLs (International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products)
• US FDA CVM guidance
• Pharmacopoeia of the People’s Republic of China (ChP) for veterinary actives
• EU Regulation (EC) No 470/2009 on veterinary residue limits

Typical usage ratio

• 7%-14% input to reactor, calculated based on final veterinary drug mass and desired steroid conversion efficiency

Downstream process integration

• Introduced during the core steroid skeleton modification reaction, preceding selective oxidation/reduction step

Final product types

• Veterinary-grade androgenic steroids (e.g., trenbolone derivatives)
• Bulk corticosteroid actives for animal injectable or implant dosage forms

3. Specialty Endocrinology Research Reagents

Biotechnology and academic research laboratories incorporate this material as a testing substrate for in vitro and in vivo hormone metabolism studies. Researchers require custom packaging, documentation, and high purity, with confirmed batch consistency and certificate of analysis. Proper segregation from cGMP manufacturing is vital to prevent cross-contamination and for compliance with laboratory safety standards.

Industry compliance standards

• ISO 9001:2015 laboratory supply quality system
• GLP (Good Laboratory Practice) for non-clinical research
• Safety Data Sheet (SDS) in line with REACH guidelines
• IATA DGR for research chemical shipping

Typical usage ratio

• Variable; 0.05–1 mg/mL in solution for cellular assays, or scaled to 50 mg–10 g per animal study batch

Downstream process integration

• Dissolved in suitable analytical-grade solvent or formulated into custom research kits prior to end user delivery

Final product types

• Validated research reagents for cell signaling assays
• Hormone pathway investigation kits for endocrine metabolite tracking

4. Chemical Reference Standard Production

Analytical labs and regulatory inspection bodies employ this product as a calibration reference for chromatographic method validation and quality control. The downstream process demands exceptional analytical purity, full impurity profiling, and stability study data. All documentation and certificate packages include isotopic traces if required, supporting regulatory submissions and routine batch testing.

Industry compliance standards

• ISO 17034:2016 (General requirements for the competence of reference material producers)
• ISO/IEC 17025:2017 laboratory accreditation
• USP Reference Standards guidelines
• OECD Test Guidelines for chemical quality

Typical usage ratio

• 20–100 mg per prepared reference ampoule; adjusted for multi-method calibration batches

Downstream process integration

• Purified by HPLC, then aliquoted and sealed into individual ampoules or vials for laboratory distribution

Final product types

• Certified reference materials (CRMs) for steroid analysis
• Analytical calibration standards for pharma and environmental monitoring

5. Contract Steroid Derivatization Services

CDMO and CRO companies rely on this compound as a feedstock for custom chemical transformation, enabling rapid prototyping and pilot scale projects. Services frequently require bespoke process adaptation, quality documentation, and robust batch records. Secure supply chain and non-GMP custom manufacturing facility segregation form key compliance commitments for contract operations.

Industry compliance standards

• ISO 9001:2015 for manufacturing management
• Project-specific quality agreements and confidentiality contracts
• Transport subject to Controlled Substance Act (CSA) in select jurisdictions
• Custom analytical release per ICH Q6A

Typical usage ratio

• 0.5–5 kg per custom batch, tailored to client protocol and final substance specification

Downstream process integration

• Input at the initial derivatization synthesis stage, followed by client-requested modifications and purification

Final product types

• Advanced steroid derivatives for lead optimization studies
• Custom intermediates for clinical trial material production